XML 89 R71.htm IDEA: XBRL DOCUMENT v3.22.1
Stock-based Compensation - Summary of Company's Restricted Stock Units And Unregistered Restricted Stock Awards Activity (Detail)
shares in Thousands
3 Months Ended
Mar. 31, 2022
$ / shares
shares
RSUs outstanding  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]  
Beginning balance (in shares) | shares 14,684
Granted (in shares) | shares 1,777
Released (in shares) | shares (1,808)
Cancelled (in shares) | shares (164)
Ending balance (in shares) | shares 14,489
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]  
Beginning balance, weighted average grant date fair value (in dollars per share) | $ / shares $ 68.03
Granted, weighted average grant date fair value (in dollars per share) | $ / shares 54.71
Released, weighted average grant date fair value (in dollars per share) | $ / shares 70.31
Cancelled , weighted average exercise price (in dollars per share) | $ / shares 66.12
Ending balance, weighted average grant date fair value (in dollars per share) | $ / shares $ 66.13
Restricted Stock Awards  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]  
Beginning balance (in shares) | shares 468
Granted (in shares) | shares 0
Released (in shares) | shares (32)
Cancelled (in shares) | shares 0
Ending balance (in shares) | shares 436
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]  
Beginning balance, weighted average grant date fair value (in dollars per share) | $ / shares $ 57.37
Granted, weighted average grant date fair value (in dollars per share) | $ / shares 0
Released, weighted average grant date fair value (in dollars per share) | $ / shares 37.75
Cancelled , weighted average exercise price (in dollars per share) | $ / shares 0
Ending balance, weighted average grant date fair value (in dollars per share) | $ / shares $ 58.80